LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 71 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $224,000 | -31.7% | 34,800 | 0.0% | 0.00% | – |
| Q4 2018 | $328,000 | -50.8% | 34,800 | +5.1% | 0.00% | -100.0% |
| Q3 2018 | $666,000 | -31.1% | 33,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $966,000 | -2.0% | 33,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $986,000 | +4.2% | 33,100 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $946,000 | -7.5% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,023,000 | +16.9% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $875,000 | -0.3% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $878,000 | +105.1% | 29,400 | +20.5% | 0.00% | 0.0% |
| Q4 2016 | $428,000 | -26.2% | 24,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $580,000 | +48.7% | 24,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $390,000 | -20.9% | 24,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $493,000 | -8.7% | 24,400 | +22.0% | 0.00% | 0.0% |
| Q4 2015 | $540,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 240,000 | $1,116,000 | 99.38% |
| TANG CAPITAL MANAGEMENT LLC | 9,607,934 | $44,677,000 | 8.98% |
| HealthInvest Partners AB | 830,000 | $3,860,000 | 5.44% |
| RTW INVESTMENTS, LP | 2,327,903 | $10,825,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 185,598 | $864,000 | 0.09% |
| WealthTrust Axiom LLC | 25,400 | $118,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 82,355 | $383,000 | 0.03% |
| FIRST MIDWEST BANK TRUST DIVISION | 41,731 | $194,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 435,387 | $2,023,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 17,176 | $80,000 | 0.01% |